ATE390927T1 - Verwendung von colesevelam oder sevelamer- hydrogenchlorid zur minderung des serumglukosegehaltes - Google Patents

Verwendung von colesevelam oder sevelamer- hydrogenchlorid zur minderung des serumglukosegehaltes

Info

Publication number
ATE390927T1
ATE390927T1 AT02726733T AT02726733T ATE390927T1 AT E390927 T1 ATE390927 T1 AT E390927T1 AT 02726733 T AT02726733 T AT 02726733T AT 02726733 T AT02726733 T AT 02726733T AT E390927 T1 ATE390927 T1 AT E390927T1
Authority
AT
Austria
Prior art keywords
serum glucose
colesevelam
hydrogen chloride
polymer
glucose content
Prior art date
Application number
AT02726733T
Other languages
English (en)
Inventor
Steven Burke
M Donovan Joanne
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE390927T1 publication Critical patent/ATE390927T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02726733T 2001-04-18 2002-04-10 Verwendung von colesevelam oder sevelamer- hydrogenchlorid zur minderung des serumglukosegehaltes ATE390927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28444501P 2001-04-18 2001-04-18
US30556401P 2001-07-13 2001-07-13

Publications (1)

Publication Number Publication Date
ATE390927T1 true ATE390927T1 (de) 2008-04-15

Family

ID=26962623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02726733T ATE390927T1 (de) 2001-04-18 2002-04-10 Verwendung von colesevelam oder sevelamer- hydrogenchlorid zur minderung des serumglukosegehaltes

Country Status (17)

Country Link
US (2) US7229613B2 (de)
EP (1) EP1392331B1 (de)
JP (2) JP4499363B2 (de)
KR (1) KR20040018358A (de)
CN (1) CN1511039A (de)
AT (1) ATE390927T1 (de)
AU (1) AU2002257145B2 (de)
BR (1) BRPI0209134B8 (de)
CA (1) CA2444046C (de)
CY (1) CY1119486T1 (de)
DE (1) DE60225908T2 (de)
DK (2) DK1392331T3 (de)
ES (2) ES2304437T3 (de)
MX (1) MXPA03009568A (de)
NZ (1) NZ528831A (de)
PT (1) PT1923064T (de)
WO (1) WO2002085377A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CN1511039A (zh) * 2001-04-18 2004-07-07 ԭ���ø� 降低血浆葡萄糖的方法
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
JPWO2005092349A1 (ja) * 2004-03-26 2008-02-07 田辺三菱製薬株式会社 インスリン抵抗性改善剤
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1830832A1 (de) * 2004-12-30 2007-09-12 Genzyme Corporation Zinkhaltige behandlungen für hyperphosphatämie
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
CA2622693C (en) 2005-09-15 2015-05-05 Genzyme Corporation Sachet formulation for amine polymers
EP1945196A2 (de) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesiumhaltige polymere für hyperphosphatämie
EP2043627A2 (de) * 2006-07-05 2009-04-08 Genzyme Corporation Eisen(ii)-haltige behandlungen für hyperphosphatämie
JP2010502590A (ja) * 2006-09-01 2010-01-28 ユーエスヴィー リミテッド セベラマー塩酸塩およびその処方物の調製のためのプロセス
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
EP2120972A1 (de) 2006-12-14 2009-11-25 Genzyme Corporation Amido-amin-polymerzusammensetzungen
EP2361171A4 (de) * 2008-09-15 2014-11-05 Shasun Chemicals And Drugs Ltd Prozess zur herstellung von vernetzten polymeren in einer nicht wässrigen lösung
WO2010086881A2 (en) * 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
WO2014122586A1 (en) 2013-02-08 2014-08-14 Wockhardt Limited Oral pharmaceutical composition of aliphatic amine polymer or salts thereof
KR20150130492A (ko) * 2013-03-15 2015-11-23 젠자임 코포레이션 개선된 최종 당화 산물(ａｇｅ) 전구체의 격리제
KR102512890B1 (ko) 2014-06-13 2023-03-21 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐 제제
MA41202A (fr) * 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
WO2018124264A1 (ja) 2016-12-28 2018-07-05 富士フイルム株式会社 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法
TW201922267A (zh) 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑
WO2023023938A1 (en) * 2021-08-24 2023-03-02 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymers, compositions and methods for treating hyperuricemia
EP4164659B1 (de) * 2021-08-24 2024-03-27 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Polymere, zusammensetzungen und verfahren zur behandlung von hyperurikämie

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528847A (en) * 1983-10-04 1985-07-16 D. Halmi And Associates, Inc. Flow metering device with recessed pressure taps
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
CA1220896A (en) * 1983-11-10 1987-04-21 Susumu Harada Process for producing polymers of monoallylamine
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
JP3507523B2 (ja) 1993-05-12 2004-03-15 積水化学工業株式会社 糖質吸収抑制剤
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
JP4156684B2 (ja) * 1996-03-05 2008-09-24 三菱化学株式会社 高リン血症予防および／または治療剤
US6203785B1 (en) * 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) * 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
FR2766195A1 (fr) * 1997-07-21 1999-01-22 Transgene Sa Polymeres cationiques, complexes associant lesdits polymeres cationiques et des substances therapeutiquement actives comprenant au moins une charges negative, notamment des acides nucleiques, et leur utilisation en therapie genique
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
AU2682499A (en) 1998-02-17 1999-08-30 Dimitri R. Kioussis Anion binding polymers and the use thereof
ATE242008T1 (de) * 1998-12-23 2003-06-15 Searle Llc Kombnationen von cholesteryl ester transfer protein inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
CN1511039A (zh) * 2001-04-18 2004-07-07 ԭ���ø� 降低血浆葡萄糖的方法
US20020198202A1 (en) * 2001-06-07 2002-12-26 Wyeth Combination of a PTPase inhibitor and an antilipemic agent

Also Published As

Publication number Publication date
CA2444046A1 (en) 2002-10-31
US7229613B2 (en) 2007-06-12
BRPI0209134B8 (pt) 2021-05-25
JP2004535384A (ja) 2004-11-25
CY1119486T1 (el) 2018-03-07
DE60225908T2 (de) 2009-05-14
WO2002085377A1 (en) 2002-10-31
DK1392331T3 (da) 2008-06-23
DK1923064T3 (en) 2017-10-02
DE60225908D1 (de) 2008-05-15
JP2010090172A (ja) 2010-04-22
JP4499363B2 (ja) 2010-07-07
EP1392331A1 (de) 2004-03-03
MXPA03009568A (es) 2004-02-12
WO2002085377A8 (en) 2002-11-28
US20070286841A1 (en) 2007-12-13
BRPI0209134B1 (pt) 2019-08-27
BR0209134A (pt) 2004-06-15
ES2304437T3 (es) 2008-10-16
ES2637020T3 (es) 2017-10-10
US20020187121A1 (en) 2002-12-12
KR20040018358A (ko) 2004-03-03
AU2002257145B2 (en) 2005-06-02
CA2444046C (en) 2011-06-07
EP1392331B1 (de) 2008-04-02
NZ528831A (en) 2005-07-29
CN1511039A (zh) 2004-07-07
PT1923064T (pt) 2017-08-23

Similar Documents

Publication Publication Date Title
ATE390927T1 (de) Verwendung von colesevelam oder sevelamer- hydrogenchlorid zur minderung des serumglukosegehaltes
DE60224052D1 (de) Aminpolymere zur behandlung von gicht und zur senkung des harnsäuregehaltes
DE69818058D1 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
CA2349620A1 (en) Use of aliphatic polyamines for reducing oxalate
BR9916785A (pt) Tratamento de asma com inibidores mek
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
NO976063L (no) Fremgangsmåte for behandling av diabetes
ATE372355T1 (de) Dl-lactid-e-caprolacton copolymere
DE69535801D1 (de) Beschleuniger des plättchenwachstums
EA200401365A1 (ru) Способы лечения илеуса
EP1362127A4 (de) Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung
DE69334101D1 (de) Verwendung von Blut mit erhöhter Stickoxidkonzentration zur Herstellung eines Medikaments
HUP0103889A2 (hu) Kopolimer-1-rokon polipeptidek alkalmazása molekulatömeg kalibráló standardként és gyógyászati anyagként
TW200519137A (en) Process for producing aliphatic polyester
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
BR9813372A (pt) ElastÈmeros de poliuretano e de poliuretano/uréia curados por calor e curados por umidade com propriedades fìsicas aperfeiçoadas
EP1923064A3 (de) Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes
BRPI0413682A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
DE69836783D1 (de) Methode zur Behandlung des Tourette-Syndroms
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
NO20003510L (no) Fett-bindende polymerer
WO2004047779A3 (en) Polymers containing quaternary ammonium salts

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1392331

Country of ref document: EP